(19)
(11) EP 2 139 522 A2

(12)

(88) Date of publication A3:
06.11.2008

(43) Date of publication:
06.01.2010 Bulletin 2010/01

(21) Application number: 08731532.1

(22) Date of filing: 06.03.2008
(51) International Patent Classification (IPC): 
A61K 47/48(2006.01)
C07D 211/94(2006.01)
A61K 31/66(2006.01)
A61P 35/00(2006.01)
C07D 207/46(2006.01)
C07F 9/54(2006.01)
A61K 31/4468(2006.01)
A61P 35/02(2006.01)
(86) International application number:
PCT/US2008/056035
(87) International publication number:
WO 2008/109740 (12.09.2008 Gazette 2008/37)
(84) Designated Contracting States:
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MT NL NO PL PT RO SE SI SK TR

(30) Priority: 06.03.2007 US 905237 P

(71) Applicants:
  • Colby Pharmaceutical Company
    Menlo Park, CA 94025 (US)
  • Medical College Of Wisconsin, Inc.
    Milwaukee, WI 53226 (US)

(72) Inventors:
  • ZARLING, David, A.
    Menlo Park, CA 94025 (US)
  • BASU, Hirak, S.
    Madison, WI 53717 (US)
  • KALYANARAMAN, Balaraman
    Wauwatosa, WI 53226 (US)
  • JOSEPH, Joy
    New Berlin, WI 53151 (US)

(74) Representative: Purdy, Hugh Barry et al
PurdyLucy Intellectual Property Suite 138/139 The Capel Building Mary's Abbey
Dublin 7
Dublin 7 (IE)

   


(54) MITOCHONDRIA TARGETED CATIONIC ANTI-OXIDANT COMPOUNDS FOR PREVENTION, THERAPY OR TREATMENT OF HYPER-PROLIFERATIVE DISEASE, NEOPLASIAS AND CANCERS